Clinical Trials Browser

Infections × Rituximab × 1 year × Clear all

NCT07614282 2026-05-29

Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia

Phase 1 Not yet recruiting

Infections, Epstein-Barr Virus Infections

NCT06790420 2026-05-15

RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study

2,703 enrolled 13 charts

Infections, Lymphoma